Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ryenklinikken AS
AS
Active
Org 992684607
Ryensvingen 3, 0680
Oslo
Traditional, complementary and alternative medicine activities
·
NACE 8696
Est. 2008 · 18 years old
3 employees
Monitor
Share
Norway
/
Companies
/
Traditional, complementary and alternative medicine activities
/
Ryenklinikken AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
10M
7M
5M
2M
0M
2021: 7M
7M
2021
2022: 7M (0% vs 2021)
7M
0%
2022
2023: 8M (+14% vs 2022)
8M
+14%
2023
2024: 8M (0% vs 2023)
8M
0%
2024
2025: 8M (0% vs 2024)
8M
0%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
7 759
8 057
7 619
6 747
6 761
Staff expenses
−4 642
−3 940
−4 138
−3 422
−3 071
EBITDA
444
1 373
535
997
1 522
Depreciation & amort.
−31
−50
−61
−69
−64
EBIT
413
1 323
474
928
1 457
Net financials
19
11
4
1
0
Profit before tax
432
1 334
478
929
1 457
Tax
100
293
105
204
322
Net profit
332
1 041
373
725
1 135
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 929
2 570
1 594
2 186
2 437
Equity
473
141
100
100
100
Long-term debt
0
0
0
0
0
Short-term debt
1 456
2 430
1 494
2 086
2 337
Total debt
1 456
2 430
1 494
2 086
2 337
Financial ratios
5-year trend
EBITDA margin
5,7 %
This company
15,8 %
Market median
This company
Market median
64% below market
2021
2025
Equity ratio
24,5 %
This company
38,2 %
Market median
This company
Market median
36% below market
2021
2025
Return on equity
70,3 %
This company
18,4 %
Market median
This company
Market median
282% above market
2021
2025
Net profit margin
4,3 %
This company
8,1 %
Market median
This company
Market median
47% below market
2021
2025
Asset turnover
4,02×
This company
1,12×
Market median
This company
Market median
259% above market
2021
2025
Debt / equity
3,08×
This company
0,62×
Market median
This company
Market median
397% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ryenklinikken AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
